TwoStep Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $62.2M

  • Investors
  • 13

TwoStep Therapeutics General Information

Description

Operator of a biotechnology platform designed to develop tumor-targeting therapeutics for solid tumors. The company offers targeted cancer therapies using an integrin-binding agent to deliver diverse therapeutic payloads to solid tumors, enabling treatment of patients with solid tumor cancers through targeted therapeutic approaches.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (423)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (423)

TwoStep Therapeutics Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TwoStep Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 22-Jul-2026 $62.2M Completed Pre-Clinical Trials
4. Accelerator/Incubator 25-Mar-2025 Completed Pre-Clinical Trials
3. Seed Round 24-Oct-2024 Completed Pre-Clinical Trials
2. Seed Round 18-Mar-2024 $6.5M $6.5M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2024 Completed Pre-Clinical Trials
To view TwoStep Therapeutics’s complete valuation and funding history, request access »

TwoStep Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view TwoStep Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TwoStep Therapeutics Patents

TwoStep Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026183433-A1 Targeted topoisomerase i inhibitor therapy for treating cancer Pending 28-Feb-2025
WO-2026096948-A1 Targeted radioligand therapy for treating cancer Pending 01-Nov-2024

TwoStep Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TwoStep Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Insight Partners (New York) PE/Buyout Minority
Medical Excellence Capital Venture Capital Minority
Merck Corporation Minority
M Ventures Corporate Venture Capital Minority
PEAK6 Investments PE/Buyout Minority
You’re viewing 5 of 13 investors. Get the full list »

TwoStep Therapeutics FAQs

  • When was TwoStep Therapeutics founded?

    TwoStep Therapeutics was founded in 2024.

  • Where is TwoStep Therapeutics headquartered?

    TwoStep Therapeutics is headquartered in San Carlos, CA.

  • What is the size of TwoStep Therapeutics?

    TwoStep Therapeutics has 10 total employees.

  • What industry is TwoStep Therapeutics in?

    TwoStep Therapeutics’s primary industry is Biotechnology.

  • Is TwoStep Therapeutics a private or public company?

    TwoStep Therapeutics is a Private company.

  • What is the current valuation of TwoStep Therapeutics?

    The current valuation of TwoStep Therapeutics is .

  • What is TwoStep Therapeutics’s current revenue?

    The current revenue for TwoStep Therapeutics is .

  • How much funding has TwoStep Therapeutics raised over time?

    TwoStep Therapeutics has raised $70.9M.

  • Who are TwoStep Therapeutics’s investors?

    Insight Partners (New York), Medical Excellence Capital, Merck, M Ventures, and PEAK6 Investments are 5 of 13 investors who have invested in TwoStep Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process